Live Breaking News & Updates on நோவர்த்திச் புற்றுநோயியல் போர்ட்‌ஃபோலீயோ மேலாண்மை

Stay updated with breaking news from நோவர்த்திச் புற்றுநோயியல் போர்ட்‌ஃபோலீயோ மேலாண்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioSpace Movers & Shakers, Dec. 18

Published: Dec 18, 2020
By Alex Keown
Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk. ....

New York , United States , Rockefeller University , United Kingdom , Terri Gaskell , Peter Greenleaf , Scott Burger , Andrea Heslin Smiley , Eli Lilly , Jeffrey Vacira , Manny Triggiano , Dmitri Daveynis , Michael Weinblatt , N Manisha Shetty Gulati , Mervyn Turner , Sandip Kapadia , D Martin Carter , Djordje Filipovic , Perry Calias , Siemens Healthineers , Marylyn Rigby , Daphne Karydas , Badreddin Edris , David Enloe , Jeff Myers , Stanley Cohen ,

AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer
AB2 BioDecember 16, 2020 GMT
Will drive commercial strategy and execution of Tadekinig alfa, currently in Phase 3
Joins AB2 Bio from Novartis and has extensive commercial and strategic experience
LAUSANNE, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) AB2 Bio Ltd., a Phase 3 clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, today announced the appointment of Djordje Filipovic, PhD, as Chief Commercial Officer (CCO).
Dr Filipovic has more than 20 years of experience as a pharmaceutical executive, covering functions in marketing, strategy, general management at local, regional and global levels as well as in research and development. In his role as CCO of AB2 Bio, Dr Filipovic will be a key member of the Executive Team, re ....

Michael Soldan , Djordje Filipovic , Marieke Vermeersch , Fernando Cunha , Ecole Polytechnique Fe , Hemophagocytic Lymphohistocytosis , Fbio Ltd , Swiss Federal Institute Of Technology , Chief Commercial Officer , Executive Team , Primary Hemophagocytic Lymphohistocytosis , Chief Executive Officer , Novartis Oncology Portfolio Management , Swiss Federal Institute , Drug Designation , Breakthrough Therapy , Pediatric Rare Disease Designations , Priority Review , Innovation Park , Sci Advisors , மைக்கேல் சொல்தான் , பெர்னாண்டோ கந்ஹ , உயிர் லிமிடெட் , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , தலைமை வணிகரீதியானது அதிகாரி , நிர்வாகி அணி ,

AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer – IT Business Net

AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Michael Soldan , Djordje Filipovic , Fernando Cunha , Ecole Polytechnique Fe , Hemophagocytic Lymphohistocytosis , Fbio Ltd , Swiss Federal Institute Of Technology , Chief Commercial Officer , Executive Team , Primary Hemophagocytic Lymphohistocytosis , Chief Executive Officer , Novartis Oncology Portfolio Management , Swiss Federal Institute , Drug Designation , Breakthrough Therapy , Pediatric Rare Disease Designations , Priority Review , Innovation Park , மைக்கேல் சொல்தான் , பெர்னாண்டோ கந்ஹ , உயிர் லிமிடெட் , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , தலைமை வணிகரீதியானது அதிகாரி , நிர்வாகி அணி , தலைமை நிர்வாகி அதிகாரி , நோவர்த்திச் புற்றுநோயியல் போர்ட்‌ஃபோலீயோ மேலாண்மை ,